Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01815112 : Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging
PhaseN/A
AgesMin: 65 Years Max: N/A
Eligibility
Inclusion Criteria:

- Age: over 65

- Participants (or representatives) gave their written informed consent

- Dementia diagnosed according to Diagnostic and Statistical Manual of Mental Disorders
(DSM IV) criteria

- For Alzheimer arm: probable Alzheimer based disease according to NINCDS-ADRDA
(National Institute of Neurological and Communicative Disorders and Stroke and the
Alzheimer's Disease and Related Disorders Association ) criteria

- For vascular dementia: diagnosis based on NINDS-AIREN (National Institute of
Neurological Disorders and Stroke and Association Internationale pour la Recherche et
l'Enseignement en Neurosciences) criteria

- For MCI: diagnosis based on Petersen index

Exclusion Criteria:

- Claustrophobia

- Diabetes

- Cardiovascular disease

- Glycemia over 1.3 g/L

- Lumbar puncture within one week before MRI examination

- Non MR-compatible implant

- Suspected brain metastases

- No informed consent signature
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01815112      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740